Clinical Trial Update: Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 pilot dose-escalation trial evaluating SBRT in combination with GC4419 in pancreatic cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• GC4419
• Stereotactic Body Radiation Therapy (SBRT) (SBRT)

Snippet

Sponsor: Galera Therapeutics, Inc. | Conditions: Pancreatic Cancer, Stereotactic Body Radiation Therapy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-15